Related Experiment Video
Updated: Mar 16, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
KCNJ4 variants disrupt inward-rectifier potassium channel function and cause refractory epilepsy.
Hu Pan1,2, Deng Liu3, Wuhen Xu4
1Key Laboratory for Birth Defects Research and Prevention of the National Health Commission, Affiliated Maternal and Child Health Care Hospital, Hengyang Medical School, University of South China (Hunan Provincial Maternal and Child Health Care Hospital), Changsha City, China.
This study identifies KCNJ4 gene variants linked to epilepsy, revealing both increased and decreased inwardly rectifying potassium channel function contribute to the neurological disorder.
Area of Science:
- Neurogenetics
- Molecular Biology
- Channelopathies
Background:
- Epilepsy is a common neurological disorder with a significant genetic component, often involving ion channel dysfunction.
- Inwardly rectifying potassium (Kir) channels are implicated in epileptogenesis, but KCNJ4's role in human epilepsy was previously unestablished.
Purpose of the Study:
- To identify pathogenic KCNJ4 variants in individuals with refractory epilepsy.
- To functionally characterize the identified KCNJ4 variants and their impact on Kir2.3 channel activity.
Main Methods:
- Whole exome sequencing was used to identify KCNJ4 variants in four unrelated individuals.
- Two-electrode voltage-clamp recordings in Xenopus oocytes assessed functional consequences of variants.
- Western blot analysis examined protein expression levels to rule out trafficking or expression artifacts.
Main Results:
- Four rare heterozygous KCNJ4 missense variants (Gly136Ser, Val206Met, Met293Lys, Glu384Lys) were identified.
- Two variants (Gly136Ser, Glu384Lys) showed gain-of-function, increasing potassium currents.
- Two variants (Val206Met, Met293Lys) showed loss-of-function, reducing potassium currents, independent of expression levels.
Conclusions:
- KCNJ4 is identified as a novel gene associated with epilepsy.
- Both gain- and loss-of-function mechanisms of Kir2.3 channels contribute to epileptogenesis.
- This expands the genetic understanding of epilepsy and highlights the therapeutic potential of targeting Kir channel function.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...

